Induction therapy with bortezomib and dexamethasone followed by autologous stem cell transplantation versus autologous stem cell transplantation alone in the treatment of renal AL amyloidosis: a randomized controlled trial

BACKGROUND: Although the use of bortezomib alone and in combination with steroids has shown efficacy in AL amyloidosis, its role in combination with high-dose melphalan and autologous stem cell transplantation (HDM/SCT) is unknown. In this study, we evaluated bortezomib in combination with dexametha...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xianghua, Wang, Qingwen, Chen, Wencui, Zeng, Caihong, Chen, Zhaohong, Gong, Dehua, Zhang, Haitao, Liu, Zhihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895846/
https://www.ncbi.nlm.nih.gov/pubmed/24386911
http://dx.doi.org/10.1186/1741-7015-12-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895846/
https://www.ncbi.nlm.nih.gov/pubmed/24386911
http://dx.doi.org/10.1186/1741-7015-12-2

Ejemplares similares